Floatz logo

Induced pluripotent stem cells (iPSCs)

Development Delay

University of Missouri-ColumbiaCell therapyActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Development Delay cohort.

Asset / SponsorPhaseRating
Zinc Acetate Dihydrate
Children's University Hospital Cologne, Germany
Phase 2B

Same molecule, other indications

Induced pluripotent stem cells (iPSCs) is also rated in:

ataxia telangiectasiaDormant
D
Indicative ·
30 / 100
View asset →
rareDormant
D
Indicative ·
30 / 100
View asset →
sleep disorderDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →